http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0114048-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
filingDate 1984-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1987-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1987-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0114048-B1
titleOfInvention Use of d,l and d-carazolole for the manufacture of antiglaucoma agents and pharmaceutical compositions containing d-carazolole
abstract The present invention is concerned with the topical use of D,L- and D-carazolol and of the pharmacologically acceptable salts in the therapy of glaucoma. The present invention is also concerned with eye drops containing these active materials.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0231444-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0231444-A3
priorityDate 1983-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2240599-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226457254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226457255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13023332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33624
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10144448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226457256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226522280

Total number of triples: 39.